Incyte to Report Third Quarter Financial Results
10 Outubro 2023 - 9:00AM
Business Wire
Incyte (Nasdaq:INCY) announced today that it has scheduled its
third quarter financial results conference call and webcast for
8:00 a.m. ET on Tuesday, October 31, 2023.
The schedule for the press release and conference call/webcast
is as follows:
- Q3 2023 Press Release: October 31, 2023 at 7:00 a.m. ET
- Q3 2023 Conference Call: October 31, 2023 at 8:00 a.m. ET
- Domestic Dial-In Number: 877-407-3042
- International Dial-In Number: 201-389-0864
- Conference ID Number: 13741786
If you are unable to participate, a replay of the conference
call will be available for thirty days. The replay dial-in number
for the U.S. is 877-660-6853 and the dial-in number for
international callers is 201-612-7415. To access the replay
you will need the conference ID number 13741786.
The live webcast with slides can be accessed at
Investor.Incyte.com and will be available for replay for ninety
days.
About Incyte
Incyte is a Wilmington, Delaware-based, global biopharmaceutical
company focused on finding solutions for serious unmet medical
needs through the discovery, development and commercialization of
proprietary therapeutics. For additional information on Incyte,
please visit Incyte.com and follow @Incyte.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231010367576/en/
Media Catalina Loveman +1 302 498 6171
cloveman@incyte.com
Investors Ben Strain +1 302 274 4773 ir@incyte.com
Incyte (NASDAQ:INCY)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Incyte (NASDAQ:INCY)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024